ClearPoint Neuro (CLPT) Research & Development (2011 - 2026)
ClearPoint Neuro recorded quarterly Research & Development of $4.5 million in Q1 2026, up 39.7% quarter-over-quarter from $3.2 million in Q4 2025, and up 33.83% year-over-year from $3.4 million in Q1 2025.
ClearPoint Neuro's Research & Development history runs 15 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Research & Development rose 33.83% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $15.0 million (up 14.41% YoY), while the FY2025 annual figure was $13.9 million, up 12.14% from the prior year.
- Research & Development came in at $4.5 million for Q1 2026 at ClearPoint Neuro, up from $3.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $4.5 million in Q1 2026 to a low of $2.4 million in Q2 2022.
- A 5-year average of $3.1 million and a median of $3.1 million in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development surged 85.6% in 2022 and slipped 13.45% in 2024, its largest moves.
- ClearPoint Neuro's Research & Development stood at $2.9 million in 2022, then declined by 9.4% to $2.7 million in 2023, then grew by 25.64% to $3.3 million in 2024, then retreated by 2.85% to $3.2 million in 2025, then jumped by 39.7% to $4.5 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $4.5 million, $3.2 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 4.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 3.38 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.65 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 3.61 Mn |
| Mar 31, 2023 | 3.02 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 2.11 Mn |
| Mar 31, 2021 | 1.56 Mn |
| Dec 31, 2020 | 1.91 Mn |
| Sep 30, 2020 | 1.14 Mn |
| Jun 30, 2020 | 812,000.00 |
| Mar 31, 2020 | 818,000.00 |
| Dec 31, 2019 | 765,776.00 |
| Sep 30, 2019 | 761,881.00 |
| Jun 30, 2019 | 697,803.00 |
| Mar 31, 2019 | 584,540.00 |
| Dec 31, 2018 | 481,293.00 |
| Sep 30, 2018 | 617,241.00 |
| Jun 30, 2018 | 665,310.00 |
| Mar 31, 2018 | 546,328.00 |
| Sep 30, 2016 | 691,330.00 |
| Jun 30, 2016 | 749,942.00 |
| Mar 31, 2016 | 657,192.00 |
| Sep 30, 2015 | 480,280.00 |
| Jun 30, 2015 | 426,931.00 |
| Mar 31, 2015 | 527,512.00 |
| Dec 31, 2014 | 707,702.00 |
| Sep 30, 2014 | 873,366.00 |
| Jun 30, 2014 | 898,423.00 |
| Mar 31, 2014 | 817,621.00 |
| Dec 31, 2013 | 684,338.00 |
| Sep 30, 2013 | 725,304.00 |
| Jun 30, 2013 | 741,817.00 |
| Mar 31, 2013 | 771,453.00 |
| Dec 31, 2012 | 735,250.00 |
| Sep 30, 2012 | 573,562.00 |
| Jun 30, 2012 | 486,022.00 |
| Mar 31, 2012 | 689,669.00 |
| Dec 31, 2011 | 1.12 Mn |
| Sep 30, 2011 | 909,910.00 |
| Jun 30, 2011 | 1.06 Mn |
| Mar 31, 2011 | 1.17 Mn |